therapeutic studies reported in the present paper indicate that the toxicity is markedly diminished by regimens requiring administration in weekly doses ( together with the standard suppressive dose of chloroquine or one of its congeners ) while its therapeutic effectiveness in the radical cure of chesson vivax malaria is increased.a weekly dose of 45 mg primaquine proved highly effective against severe chesson vivax infections when administered for eight weeks .
C0024537
vivax malaria
C0033126
primaquine